Phase II study of paclitaxel plus the protein kinase C inhibitor bryostatin-1 in advanced pancreatic carcinoma.

Anthony P Lam; Joseph A Sparano; Vincent Vinciguerra; Allyson J Ocean; Paul Christos; Howard Hochster; Fernando Camacho; Sanjay Goel; Sridhar Mani; Andreas Kaubisch

doi:10.1097/COC.0b013e3181a31920

Phase II study of paclitaxel plus the protein kinase C inhibitor bryostatin-1 in advanced pancreatic carcinoma.

Identifier:nobleid.org/w1/20260515/DF820A4D

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/DF820A4D.svg?ark=w1%2F20260515%2FDF820A4D)](https://nobleid.org/work/w1/20260515/DF820A4D)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Phase II study of paclitaxel plus the protein kinase C inhibitor bryostatin-1 in advanced pancreatic carcinoma.

Identifier:nobleid.org/w1/20260515/DF820A4D

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/DF820A4D.svg?ark=w1%2F20260515%2FDF820A4D)](https://nobleid.org/work/w1/20260515/DF820A4D)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work